Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma

Leukemia and Lymphoma

Volumn 42, Issue 4, 2001, Pages 639-647

  Kanda, M ^a   Suzumiya, J ^a   Ohshima, K ^a   Okada, M ^a   Tamura, K ^a   Kikuchi, M ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Eradication; Helicobacter pyroli (H. pylori); IgH; Mucosa associated lymphoid tissue (MALT) lymphoma; PCR

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; IMMUNOGLOBULIN HEAVY CHAIN; METRONIDAZOLE; MONOCLONAL ANTIBODY KI 67; PROTON PUMP INHIBITOR; ROXITHROMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CELL DENSITY; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ERADICATION THERAPY; FEMALE; GENE AMPLIFICATION; GENE REARRANGEMENT; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; STAINING; STOMACH LESION; STOMACH LYMPHOMA; TREATMENT OUTCOME;

EID: 0034877154     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109099324     Document Type: Article

References (47)

1. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
2. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
3. Antibiotic treatment for low-grade gastric MALT lymphoma
4. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis
5. B-cell lymphoma of MALT type: A review with special emphasis on diagnostic and management problems of low-grade gastric tumors
6. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: Histology, polymerase chain reaction, or both?
7. Identification of monoclonal B-cell populations by rapid cycle polymerase chain reaction. A practical screening method for the detection of immunoglobulin gene rearrangements
8. Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction
9. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction
10. Monoclonality in B-lymphoproliferative disorders detected at the DNA level
11. Clonality analysis of defined B-cell populations in archival tissue sections using microdissection and the polymerase chain reaction
12. Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction
13. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type
14. The use of the polymerase chain reaction in the diagnosis of B-cell lymphomas from formalin-fixed paraffin-embedded tissue
15. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population
16. Analysis of low and high grade B-cell lymphoma subtypes using semi-nested PCR and two primer sets
17. Cell turnover parameters in small and large cell varieties of primary intestinal non-Hodgkin's lymphoma
18. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas
19. Monoclonal antibody Ki-67: Its use in histopathology
20. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens
21. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms
22. Determination of B-cell clonality in paraffin-embedded lymph nodes using the polymerase chain reaction
23. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens
24. Sample preparation from paraffin-embedded tissues
25. Intravascular large cell lymphoma: Clinicopathological, immuno-histochemical and molecular genetic studies
26. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
27. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
28. Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma
29. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies
30. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma
31. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment
32. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
33. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging
34. The gastric marginal zone B-cell lymphoma of MALT type
35. Molecular genetics of extranodal marginal zone (MALT-type) B-cell lymphoma
36. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey
37. How do you distinguish benign from malignant extranodal small B-cell proliferations?
38. What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites?
39. Are there site-specific differences among the MALT lymphomas-morphologic, clinical?
40. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type
41. PCR-based clonality analysis: A reliable method for the diagnosis and follow-up monitoring of conservatively treated gastric B-cell MALT lymphomas?
42. Polymerase chain reaction in the assessment of lymphomas
43. Gastric MALT lymphoma: From concept to cure
44. Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody
45. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma
46. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67
47. Immunophenotyping in the management of gastric lymphoma